naphthalimides has been researched along with Pituitary Neoplasms in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Bi, Y; Chen, Y; Dong, J; Dou, G; Hu, F; Jiang, S; Liu, G; Wang, X; Wu, B; Wu, Y; Yi, D; Zhong, S | 1 |
1 other study(ies) available for naphthalimides and Pituitary Neoplasms
Article | Year |
---|---|
Identification of driver genes and key pathways of non-functional pituitary adenomas predicts the therapeutic effect of STO-609.
Topics: Animals; Antineoplastic Agents; Benzimidazoles; Calcium-Calmodulin-Dependent Protein Kinase Kinase; Cell Line, Tumor; Computational Biology; Gene Expression Profiling; Gene Ontology; Humans; Mice; Microarray Analysis; Naphthalimides; Pituitary Neoplasms; Protein Kinase Inhibitors; Signal Transduction | 2020 |